文献速递慢性肾脏病肾小球疾病遗传性与小管间质肾病

APOL1介导肾病ICD-10编码的设立与意义

ICD-10 codes for APOL1-mediated kidney disease.
PubMed 文献 · Kidney Int · 2026-01-01

本文介绍美国新设立的APOL1介导肾病(AMKD)及家族史ICD-10临床修改编码,指出既往模糊诊断编码导致非洲裔非糖尿病人群误分类,影响流行病学与科研。呼吁肾内科医生积极识别、基因分型并正确编码AMKD患者,以促进早期发现和临床试验入组。

要点

  • 新ICD-10编码覆盖AMKD及家族史,有助纠正非洲裔患者误分类。
  • 缺乏AMKD诊断编码曾干扰肾衰竭流行病学并延迟研究。
  • 肾内科医生应警惕识别、基因分型并正确编码AMKD患者。

核心结论

  • 新ICD-10编码为AMKD及家族史提供专门标识,有望改善非洲裔慢性肾脏病患者的识别与研究。

研究设计与样本

  • 本文为评论性文章,未报告系统综述或原始研究的设计与样本量。

主要发现

  • 既往模糊诊断编码迫使许多非洲裔非糖尿病人群被误分类。
  • 美国肾脏数据系统及国际登记缺乏AMKD诊断,影响公共卫生并延迟研究。

关键数值与推荐

  • 美国新设APOL1介导肾病及家族史的ICD-10临床修改编码。

临床怎么用

  • 肾内科医生应警惕识别、基因分型并正确编码AMKD患者。
  • 早期发现AMKD有助于患者入组临床试验。

局限性

  • 原文未报告新编码的具体应用数据或验证结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

New International Classification of Disease-10th Edition-Clinical Modification codes for APOL1-mediated kidney disease (AMKD) and family history of AMKD in the United States provide great hope to the millions of people with recent African ancestry and chronic kidney disease worldwide. In the past, vague diagnosis codes forced misclassification of many such patients, especially nondiabetic persons of African ancestry. The lack of an AMKD diagnosis in the US Renal Data System and international registries has had profound effects on public health, confusing the epidemiology of kidney failure and delaying research for more accurate diagnoses and treatments. With these codes, nephrologists and providers caring for patients with and at risk for chronic kidney disease must be vigilant to identify, genotype, and appropriately code patients with AMKD. We owe it to our patients and future generations in their families to detect AMKD at earlier stages. This will permit their enrollment into clinical trials that provide hope for a cure.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Freedman BI, Gillespie BS, Egbuna OI, et al. ICD-10 codes for APOL1-mediated kidney disease. Kidney Int. 2026. PMID: 41577386. doi:10.1016/j.kint.2025.09.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。